Century Therapeutics (IPSC) Q1 2026 Earnings
IPSC·Reported May 13, 2026·Before market open
Diluted EPS came in at $-0.11, beat the $-0.15 consensus by $0.04.
Diluted EPS
$-0.11beat by $0.04
Consensus: $-0.15
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Century Therapeutics's Q1 2026 earnings report.
Century Therapeutics (IPSC) reported Q1 2026 earnings on May 13, 2026 before market open.
Century Therapeutics reported diluted EPS of $-0.11 for Q1 2026.
EPS beat the consensus estimate of $-0.15 by $0.04.
You can read the 8-K earnings release (0001104659-26-059824) and the 10-Q periodic report (0001104659-26-059816) directly on SEC EDGAR. The filing index links above go to sec.gov.